SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCGT again

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Ucci who wrote (113)10/15/1997 9:38:00 AM
From: Stock Puppy   of 283
 
Quarterly report out!
We are of 1,438 (# of holders of this stock :-))
View at:

edgar-online.com
and:
sec.yahoo.com

misc highlights, must read the above docs for better picture though:

Results of Operations
---------------------
Total revenues increased to $ 842,815 for the year ended June 30, 1997 from $746,006 for 1996. Cost of sales increased $77,132. The increase in revenues was primarily due to an increase in revenues from sales and services of third party software products.

Marketing general and administrative expenses decreased $979,849 for the year ended June 30, 1997 as compared to 1996 due primarily to the difference in non-cash expenses related to the issuance of warrants to employees and outside consultants.

.......experienced recurring losses
from operations and has been unable to provide sufficient working capital from operations and has relied significantly on the sale of equity interests in the Company and loans from officers and shareholders to fund its operations.......

Year Ended June 30,
---------------------
1997 1996

REVENUES:
Net sales of third party software
and support services $ 793,549 $ 723,964
Net sales of medical products 3,861 6,068
Fees charged to medical providers 45,405 15,974
------------ ------------
TOTAL REVENUES 842,815 746,006

COSTS AND EXPENSES:
Cost of sales 405,692 328,560
Marketing, general and administrative 1,172,908 2,152,757
Depreciation and amortization 748,220 732,194
Interest - net (2,042) 1,247
------------ ------------
TOTAL COSTS AND EXPENSES 2,324,778 3,214,758
------------ ------------
NET LOSS $ (1,481,963) $ (2,468,752)
============ ============
NET LOSS PER COMMON SHARE $ (.06) $ (.12)
============ ============
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING 23,716,575 21,226,848
============ ============
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext